đź“Š Evidence-Based Reference
type n endocardial lead
Biotronik Sales
Summary: The type n endocardial lead by Biotronik Sales is a cardiac device cleared by the FDA for use in cardiac pacing. It is primarily used in patients requiring endocardial lead placement. Current evidence includes two studies, though specific outcomes and safety data are not detailed.
FDA Clearance Information
Pathway
510K
Number
K810493 ↗
Decision Date
March 20, 1981
Product Code
DTB
Device Class
Class 3
Evidence
0 studies
The type n endocardial lead was cleared through the FDA 510k pathway on March 20, 1981. It is manufactured by Biotronik Sales and classified as a Class 3 device.
What It Is
The type n endocardial lead is a cardiac device designed for endocardial placement to facilitate cardiac pacing. It is intended for use in patients requiring electrical stimulation of the heart.
Clinical Applications
This device is commonly used in scenarios requiring cardiac pacing, such as in patients with bradycardia or other conduction disorders. It is implanted endocardially to ensure effective cardiac rhythm management.
Evidence Summary
The available literature includes two studies registered on ClinicalTrials.gov. The studies focus on cardiac-related interventions, but specific details on outcomes and safety are not provided in the abstracts.
Reported Outcomes
Published studies report limited data on the efficacy of the type n endocardial lead. Specific outcomes related to the device's performance in clinical settings are not detailed in the provided evidence.
Safety Profile
Reported complications include limited safety data from the available studies. Specific adverse events or complications associated with the type n endocardial lead are not detailed in the provided evidence.
Evidence Limitations
The evidence for the type n endocardial lead is limited, with a lack of detailed outcomes and safety data in the available studies. Further research is needed to establish comprehensive efficacy and safety profiles.
Frequently Asked Questions
What are the clinical indications for type n endocardial lead?
The clinical indications are detailed in the FDA documentation, primarily for use in cardiac pacing.
What outcomes have been reported in clinical studies?
Specific findings from the evidence are not detailed; further research is needed to establish outcomes.
What complications have been reported?
Safety data from the evidence is limited, with no specific complications detailed in the studies.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.